List of Tables
Table 1. Global Janus Kinase Inhibitors Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Janus Kinase Inhibitors Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Janus Kinase Inhibitors Market Competitive Situation by Manufacturers in 2025
Table 4. Global Janus Kinase Inhibitors Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Janus Kinase Inhibitors Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Janus Kinase Inhibitors Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Janus Kinase Inhibitors Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Janus Kinase Inhibitors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Janus Kinase Inhibitors, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Janus Kinase Inhibitors, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Janus Kinase Inhibitors, Product Types and Applications
Table 12. Global Key Manufacturers of Janus Kinase Inhibitors, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Janus Kinase Inhibitors Companies by Tier (Tier 1, Tier 2, Tier 3), based on Janus Kinase Inhibitors Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Janus Kinase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Janus Kinase Inhibitors Sales by Region (K Units), 2021–2026
Table 18. Global Janus Kinase Inhibitors Sales Market Share by Region (2021–2026)
Table 19. Global Janus Kinase Inhibitors Sales by Region (K Units), 2027–2032
Table 20. Global Janus Kinase Inhibitors Sales Market Share by Region (2027–2032)
Table 21. Global Janus Kinase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 22. Global Janus Kinase Inhibitors Revenue Market Share by Region (2021–2026)
Table 23. Global Janus Kinase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 24. Global Janus Kinase Inhibitors Revenue Market Share by Region (2027–2032)
Table 25. North America Janus Kinase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Janus Kinase Inhibitors Sales by Country (K Units), 2021–2026
Table 27. North America Janus Kinase Inhibitors Sales by Country (K Units), 2027–2032
Table 28. North America Janus Kinase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 29. North America Janus Kinase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Janus Kinase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Janus Kinase Inhibitors Sales by Country (K Units), 2021–2026
Table 32. Europe Janus Kinase Inhibitors Sales by Country (K Units), 2027–2032
Table 33. Europe Janus Kinase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Janus Kinase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Janus Kinase Inhibitors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Janus Kinase Inhibitors Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Janus Kinase Inhibitors Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Janus Kinase Inhibitors Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Janus Kinase Inhibitors Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Janus Kinase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Janus Kinase Inhibitors Sales by Country (K Units), 2021–2026
Table 42. Latin America Janus Kinase Inhibitors Sales by Country (K Units), 2027–2032
Table 43. Latin America Janus Kinase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Janus Kinase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Janus Kinase Inhibitors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Janus Kinase Inhibitors Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Janus Kinase Inhibitors Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Janus Kinase Inhibitors Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Janus Kinase Inhibitors Revenue by Country (US$ Million), 2027–2032
Table 50. Global Janus Kinase Inhibitors Sales (K Units) by Type (2021–2026)
Table 51. Global Janus Kinase Inhibitors Sales (K Units) by Type (2027–2032)
Table 52. Global Janus Kinase Inhibitors Sales Market Share by Type (2021–2026)
Table 53. Global Janus Kinase Inhibitors Sales Market Share by Type (2027–2032)
Table 54. Global Janus Kinase Inhibitors Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Janus Kinase Inhibitors Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Janus Kinase Inhibitors Revenue Market Share by Type (2021–2026)
Table 57. Global Janus Kinase Inhibitors Revenue Market Share by Type (2027–2032)
Table 58. Global Janus Kinase Inhibitors Price (US$/Unit) by Type (2021–2026)
Table 59. Global Janus Kinase Inhibitors Price (US$/Unit) by Type (2027–2032)
Table 60. Global Janus Kinase Inhibitors Sales (K Units) by Application (2021–2026)
Table 61. Global Janus Kinase Inhibitors Sales (K Units) by Application (2027–2032)
Table 62. Global Janus Kinase Inhibitors Sales Market Share by Application (2021–2026)
Table 63. Global Janus Kinase Inhibitors Sales Market Share by Application (2027–2032)
Table 64. Global Janus Kinase Inhibitors Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Janus Kinase Inhibitors Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Janus Kinase Inhibitors Revenue Market Share by Application (2021–2026)
Table 67. Global Janus Kinase Inhibitors Revenue Market Share by Application (2027–2032)
Table 68. Global Janus Kinase Inhibitors Price (US$/Unit) by Application (2021–2026)
Table 69. Global Janus Kinase Inhibitors Price (US$/Unit) by Application (2027–2032)
Table 70. Pfizer Company Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Pfizer Janus Kinase Inhibitors Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Eli Lilly Company Information
Table 76. Eli Lilly Description and Business Overview
Table 77. Eli Lilly Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. Eli Lilly Janus Kinase Inhibitors Product
Table 79. Eli Lilly Recent Developments/Updates
Table 80. Novartis Company Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. Novartis Janus Kinase Inhibitors Product
Table 84. Novartis Recent Developments/Updates
Table 85. Incyte Company Information
Table 86. Incyte Description and Business Overview
Table 87. Incyte Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Incyte Janus Kinase Inhibitors Product
Table 89. Incyte Recent Developments/Updates
Table 90. Astellas Pharma Company Information
Table 91. Astellas Pharma Description and Business Overview
Table 92. Astellas Pharma Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Astellas Pharma Janus Kinase Inhibitors Product
Table 94. Astellas Pharma Recent Developments/Updates
Table 95. Torii Pharmaceutical Company Information
Table 96. Torii Pharmaceutical Description and Business Overview
Table 97. Torii Pharmaceutical Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. Torii Pharmaceutical Janus Kinase Inhibitors Product
Table 99. Torii Pharmaceutical Recent Developments/Updates
Table 100. LEO Pharma Company Information
Table 101. LEO Pharma Description and Business Overview
Table 102. LEO Pharma Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. LEO Pharma Janus Kinase Inhibitors Product
Table 104. LEO Pharma Recent Developments/Updates
Table 105. Bristol Myers Squibb Company Information
Table 106. Bristol Myers Squibb Description and Business Overview
Table 107. Bristol Myers Squibb Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Bristol Myers Squibb Janus Kinase Inhibitors Product
Table 109. Bristol Myers Squibb Recent Developments/Updates
Table 110. CTI BioPharma Company Information
Table 111. CTI BioPharma Description and Business Overview
Table 112. CTI BioPharma Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. CTI BioPharma Janus Kinase Inhibitors Product
Table 114. CTI BioPharma Recent Developments/Updates
Table 115. AbbVie Company Information
Table 116. AbbVie Description and Business Overview
Table 117. AbbVie Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. AbbVie Janus Kinase Inhibitors Product
Table 119. AbbVie Recent Developments/Updates
Table 120. Alfasigma Company Information
Table 121. Alfasigma Description and Business Overview
Table 122. Alfasigma Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Alfasigma Janus Kinase Inhibitors Product
Table 124. Alfasigma Recent Developments/Updates
Table 125. Gilead Sciences Company Information
Table 126. Gilead Sciences Description and Business Overview
Table 127. Gilead Sciences Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. Gilead Sciences Janus Kinase Inhibitors Product
Table 129. Gilead Sciences Recent Developments/Updates
Table 130. Eisai Company Information
Table 131. Eisai Description and Business Overview
Table 132. Eisai Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 133. Eisai Janus Kinase Inhibitors Product
Table 134. Eisai Recent Developments/Updates
Table 135. Hetero Company Information
Table 136. Hetero Description and Business Overview
Table 137. Hetero Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 138. Hetero Janus Kinase Inhibitors Product
Table 139. Hetero Recent Developments/Updates
Table 140. Zydus Company Information
Table 141. Zydus Description and Business Overview
Table 142. Zydus Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 143. Zydus Janus Kinase Inhibitors Product
Table 144. Zydus Recent Developments/Updates
Table 145. Natco Pharma Company Information
Table 146. Natco Pharma Description and Business Overview
Table 147. Natco Pharma Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 148. Natco Pharma Janus Kinase Inhibitors Product
Table 149. Natco Pharma Recent Developments/Updates
Table 150. Cipla Company Information
Table 151. Cipla Description and Business Overview
Table 152. Cipla Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 153. Cipla Janus Kinase Inhibitors Product
Table 154. Cipla Recent Developments/Updates
Table 155. Simcere Pharmaceutical Company Information
Table 156. Simcere Pharmaceutical Description and Business Overview
Table 157. Simcere Pharmaceutical Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 158. Simcere Pharmaceutical Janus Kinase Inhibitors Product
Table 159. Simcere Pharmaceutical Recent Developments/Updates
Table 160. Chia Tai Tianqing Pharmaceutical Company Information
Table 161. Chia Tai Tianqing Pharmaceutical Description and Business Overview
Table 162. Chia Tai Tianqing Pharmaceutical Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 163. Chia Tai Tianqing Pharmaceutical Janus Kinase Inhibitors Product
Table 164. Chia Tai Tianqing Pharmaceutical Recent Developments/Updates
Table 165. Qilu Pharmaceutical Company Information
Table 166. Qilu Pharmaceutical Description and Business Overview
Table 167. Qilu Pharmaceutical Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 168. Qilu Pharmaceutical Janus Kinase Inhibitors Product
Table 169. Qilu Pharmaceutical Recent Developments/Updates
Table 170. Chengdu Easton Biopharmaceuticals Company Information
Table 171. Chengdu Easton Biopharmaceuticals Description and Business Overview
Table 172. Chengdu Easton Biopharmaceuticals Janus Kinase Inhibitors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 173. Chengdu Easton Biopharmaceuticals Janus Kinase Inhibitors Product
Table 174. Chengdu Easton Biopharmaceuticals Recent Developments/Updates
Table 175. Key Raw Materials Lists
Table 176. Raw Materials Key Suppliers Lists
Table 177. Janus Kinase Inhibitors Distributors List
Table 178. Janus Kinase Inhibitors Customers List
Table 179. Janus Kinase Inhibitors Market Trends
Table 180. Janus Kinase Inhibitors Market Drivers
Table 181. Janus Kinase Inhibitors Market Challenges
Table 182. Janus Kinase Inhibitors Market Restraints
Table 183. Research Programs/Design for This Report
Table 184. Key Data Information from Secondary Sources
Table 185. Key Data Information from Primary Sources
Table 186. Authors List of This Report
List of Figures
Figure 1. Product Picture of Janus Kinase Inhibitors
Figure 2. Global Janus Kinase Inhibitors Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Janus Kinase Inhibitors Market Share by Type: 2025 & 2032
Figure 4. Selective JAK Inhibitors Product Picture
Figure 5. Non-selective JAK Inhibitors Product Picture
Figure 6. Global Janus Kinase Inhibitors Market Value by Application (US$ Million), 2021–2032
Figure 7. Global Janus Kinase Inhibitors Market Share by Application: 2025 & 2032
Figure 8. Autoimmune Diseases
Figure 9. Blood System Diseases
Figure 10. Skin Diseases
Figure 11. Other
Figure 12. Global Janus Kinase Inhibitors Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Janus Kinase Inhibitors Market Size (US$ Million), 2021–2032
Figure 14. Global Janus Kinase Inhibitors Sales (K Units), 2021–2032
Figure 15. Global Janus Kinase Inhibitors Average Price (US$/Unit), 2021–2032
Figure 16. Janus Kinase Inhibitors Report Years Considered
Figure 17. Janus Kinase Inhibitors Sales Share by Manufacturers in 2025
Figure 18. Global Janus Kinase Inhibitors Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Janus Kinase Inhibitors Players: Market Share by Revenue in Janus Kinase Inhibitors in 2025
Figure 20. Janus Kinase Inhibitors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Janus Kinase Inhibitors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Janus Kinase Inhibitors Sales Market Share by Country (2021–2032)
Figure 23. North America Janus Kinase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 24. United States Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Janus Kinase Inhibitors Sales Market Share by Country (2021–2032)
Figure 27. Europe Janus Kinase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 28. Germany Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Janus Kinase Inhibitors Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Janus Kinase Inhibitors Revenue Market Share by Region (2021–2032)
Figure 35. China Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Janus Kinase Inhibitors Sales Market Share by Country (2021–2032)
Figure 43. Latin America Janus Kinase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Janus Kinase Inhibitors Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Janus Kinase Inhibitors Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Janus Kinase Inhibitors Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Janus Kinase Inhibitors by Type (2021–2032)
Figure 54. Global Revenue Market Share of Janus Kinase Inhibitors by Type (2021–2032)
Figure 55. Global Janus Kinase Inhibitors Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Janus Kinase Inhibitors by Application (2021–2032)
Figure 57. Global Revenue Market Share of Janus Kinase Inhibitors by Application (2021–2032)
Figure 58. Global Janus Kinase Inhibitors Price (US$/Unit) by Application (2021–2032)
Figure 59. Janus Kinase Inhibitors Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
